Mechanistic studies revealed that silencing METTL3 in the DLBCL cells led to a reduction in m6A methylation in PEDF transcripts and mRNA expression of PEDF, thereby inhibiting Wnt signaling activities. The gene discussed is METTL3; the disease is diffuse large B-cell lymphoma.